Kesselring J. , Miller DH, Robb SA, et al: Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis . Brain1990;113:291-302.
2.
Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med1992;326:107-116.
3.
Soueidan SA, Dalakas MC: Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr Res1993;33:S95-S100.
4.
Sourojon MC, Fuchs S.: Anti-idiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis. Ann N Y Acad Sci1987;505:676-682.
5.
Liblau R., Gajdus P., Bustarret A., et al: Intravenous globulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies. J Clin Immunol1991;11:128-131.
6.
Koski CL: Complement-fixing antiperipheral myelin antibodies and C9 neoantigens in serum of patients with Guillain-Barré syndrome: Quantitation, kinetics and clinical correlation. Ann N YAcad Sci1987;505:319-325.
7.
van der Meche FG, Schmitz P, DutchGuillain-Barré Study Group: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl JMed1992 ;326:1123-1129.
8.
Heaton P.: Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin. N Z Med J1992;105: 477-478.
9.
Cornblath DR , Chaudhry V., Griffin JW: Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin . Ann Neurol1991;30:104-106.
10.
Hartung HP: Immune-mediated demyelination. Ann Neurol1993;33:563-567.
11.
Sharief MK, McLean B., Thompson EJ: Elevated serum levels of tumor necrosis factor in Guillain-Barré syndrome . Ann Neurol1993;33:591-596.
12.
Hofman FM, Hinton DR, Johnson K., Merril JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med1989; 170:607-612.
13.
Kuroda Y., Shimamoto Y.: Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J Neuroimmunol1991;34:159-164.
14.
Ruddle NH, Bergman CM, McGrath KM, et al: An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med1990;172: 1193-1200.
15.
Cannella B. , Cross AH, Raine CS: Adhesion-related molecules in the central nervous system. Up-regulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab Invest1991;65:23-31.
16.
Archelos JJ , Jung S., Maurer M., et al: Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1 . Ann Neurol1993;34:145-154.
17.
Marks WA, Shuman RM, Bodensteiner JB: HLA patterns in children with parainflammatory leukoencephalomyelitis . J Child Neurol1991;6:150-154.
18.
Woody RC, Steele RW, Charlton RK, Smith V.: Histocompatibility determinants in childhood post-infectious encephalomyelitis . J Child Neurol1989;4:203-206.
